ANEST IWATA Corporation (TYO:6381)
Japan · Delayed Price · Currency is JPY 1,803.00
+3.00 (0.17%)
Jul 31, 2026, 3:30 PM JST
ANEST IWATA Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 55,909 | 54,411 | 53,425 | 48,515 | 42,337 | |
Revenue Growth | 2.75% | 1.85% | 10.12% | 14.59% | 18.96% |
Cost of Revenue | 29,766 | 29,091 | 28,950 | 27,178 | 24,109 |
Gross Profit | 26,143 | 25,320 | 24,475 | 21,337 | 18,228 |
Selling, General & Admin | 20,016 | 19,023 | 17,869 | 15,184 | 13,242 |
Other Operating Expenses | 159 | 235 | 330 | 175 | 201 |
Operating Expenses | 20,580 | 19,417 | 18,299 | 15,498 | 13,447 |
Operating Income | 5,563 | 5,903 | 6,176 | 5,839 | 4,781 |
Interest Expense | -67 | -106 | -72 | -58 | -58 |
Interest & Investment Income | 290 | 298 | 246 | 139 | 126 |
Earnings From Equity Investments | 1,056 | 936 | 768 | 523 | 359 |
Currency Exchange Gain (Loss) | 467 | 21 | 739 | 464 | 231 |
Other Non Operating Income (Expenses) | 409 | 85 | 128 | 134 | 131 |
EBT Excluding Unusual Items | 7,718 | 7,137 | 7,985 | 7,041 | 5,570 |
Gain (Loss) on Sale of Investments | - | 143 | 14 | 56 | -23 |
Gain (Loss) on Sale of Assets | 770 | 21 | 10 | 8 | 3 |
Asset Writedown | -38 | -6 | -23 | -16 | -10 |
Other Unusual Items | 22 | -26 | - | - | - |
Pretax Income | 8,472 | 7,269 | 7,986 | 7,089 | 5,540 |
Income Tax Expense | 2,159 | 1,904 | 2,052 | 1,821 | 1,392 |
Earnings From Continuing Operations | 6,313 | 5,365 | 5,934 | 5,268 | 4,148 |
Minority Interest in Earnings | -957 | -1,089 | -1,003 | -887 | -607 |
Net Income | 5,356 | 4,276 | 4,931 | 4,381 | 3,541 |
Net Income to Common | 5,356 | 4,276 | 4,931 | 4,381 | 3,541 |
Net Income Growth | 25.26% | -13.28% | 12.55% | 23.72% | 35.00% |
Shares Outstanding (Basic) | 39 | 40 | 40 | 40 | 41 |
Shares Outstanding (Diluted) | 39 | 40 | 40 | 40 | 41 |
Shares Change | -0.38% | -2.11% | -0.26% | -1.34% | -0.94% |
EPS (Basic) | 136.03 | 108.19 | 122.13 | 108.23 | 86.31 |
EPS (Diluted) | 136.03 | 108.19 | 122.13 | 108.23 | 86.31 |
EPS Growth | 25.74% | -11.42% | 12.84% | 25.40% | 36.28% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 4,942 | 7,083 | 4,952 | 2,482 | 3,023 |
Free Cash Flow Per Share | 125.52 | 179.21 | 122.65 | 61.32 | 73.68 |
Dividend Per Share | 87.000 | 45.000 | 49.000 | 38.000 | 30.000 |
Dividend Growth | 93.33% | -8.16% | 28.95% | 26.67% | 25.00% |
Gross Margin | 46.76% | 46.53% | 45.81% | 43.98% | 43.05% |
Operating Margin | 9.95% | 10.85% | 11.56% | 12.04% | 11.29% |
Profit Margin | 9.58% | 7.86% | 9.23% | 9.03% | 8.36% |
Free Cash Flow Margin | 8.84% | 13.02% | 9.27% | 5.12% | 7.14% |
EBITDA | 8,047 | 8,388 | 8,427 | 7,914 | 6,545 |
EBITDA Margin | 14.39% | 15.42% | 15.77% | 16.31% | 15.46% |
D&A For EBITDA | 2,484 | 2,485 | 2,251 | 2,075 | 1,764 |
EBIT | 5,563 | 5,903 | 6,176 | 5,839 | 4,781 |
EBIT Margin | 9.95% | 10.85% | 11.56% | 12.04% | 11.29% |
Effective Tax Rate | 25.48% | 26.19% | 25.70% | 25.69% | 25.13% |